These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 10210968)

  • 1. [Antiretroviral treatment].
    Nielsen HI
    Ugeskr Laeger; 1999 Mar; 161(12):1731. PubMed ID: 10210968
    [No Abstract]   [Full Text] [Related]  

  • 2. Delayed HIV-1 seroconversion after antiretroviral therapy.
    Apetrei C; Tamalet C; Edlinger C; Damond F; Descamps D; Saimot AG; Brun-Vézinet F; Simon F
    AIDS; 1998 Oct; 12(14):1935-6. PubMed ID: 9792400
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of chronic hepatitis C in patients with HIV coinfection: efficacy and tolerance].
    Pol S
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B264-73. PubMed ID: 12180300
    [No Abstract]   [Full Text] [Related]  

  • 4. Antiretroviral activity of emtricitabine, a potent nucleoside reverse transcriptase inhibitor.
    Richman DD
    Antivir Ther; 2001 Jun; 6(2):83-8. PubMed ID: 11491420
    [No Abstract]   [Full Text] [Related]  

  • 5. Potential effect of HIV type 1 antiretroviral and herpes simplex virus type 2 antiviral therapy on transmission and acquisition of HIV type 1 infection.
    Celum CL; Robinson NJ; Cohen MS
    J Infect Dis; 2005 Feb; 191 Suppl 1():S107-14. PubMed ID: 15627220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy.
    Pozniak A; Gazzard B; Anderson J; Babiker A; Churchill D; Collins S; Fisher M; Johnson M; Khoo S; Leen C; Loveday C; Moyle G; Nelson M; Peter B; Phillips A; Pillay D; Wilkins E; Williams I; Youle M;
    HIV Med; 2003 Oct; 4 Suppl 1():1-41. PubMed ID: 14511246
    [No Abstract]   [Full Text] [Related]  

  • 7. [Efficacy and tolerance of antiretroviral therapy in HIV-2 infected patients in Dakar: preliminary study].
    Ndour CT; Batista G; Manga NM; Guèye NF; Badiane NM; Fortez L; Sow PS
    Med Mal Infect; 2006 Feb; 36(2):111-4. PubMed ID: 16480843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [What is the patient's HIV status?].
    Christiansen CB
    Ugeskr Laeger; 2000 May; 162(20):2912. PubMed ID: 10860440
    [No Abstract]   [Full Text] [Related]  

  • 9. Risks and benefits of antiretroviral therapy in HIV-HCV co-infected patients.
    Núñez M; Soriano V
    J Hepatol; 2005 Mar; 42(3):290-2. PubMed ID: 15710208
    [No Abstract]   [Full Text] [Related]  

  • 10. The downside of success: confirmation of HIV infection in early treated children.
    Sutcliffe CG; Moss WJ
    Lancet Infect Dis; 2015 Jul; 15(7):751-2. PubMed ID: 26043883
    [No Abstract]   [Full Text] [Related]  

  • 11. Antiretroviral drug resistance and resistance testing.
    Gallant JE
    Top HIV Med; 2005 Dec-2006 Jan; 13(5):138-42. PubMed ID: 16377851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunovirological and therapeutic follow-up of HIV-1/HIV-2-dually seropositive patients.
    Landman R; Damond F; Gerbe J; Brun-Vezinet F; Yeni P; Matheron S
    AIDS; 2009 Jan; 23(3):426-8. PubMed ID: 19114866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virologic and immunologic responses to antiretroviral therapy among HIV-1 and HIV-2 dually infected patients: case reports from Abidjan, Côte d'Ivoire.
    Borget MY; Diallo K; Adje-Toure C; Chorba T; Nkengasong JN
    J Clin Virol; 2009 May; 45(1):72-5. PubMed ID: 19375979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imidazopyridine-5,6,7,8-tetrahydro-8-quinolinamine derivatives with potent activity against HIV-1.
    Gudmundsson KS; Boggs SD; Catalano JG; Svolto A; Spaltenstein A; Thomson M; Wheelan P; Jenkinson S
    Bioorg Med Chem Lett; 2009 Nov; 19(22):6399-403. PubMed ID: 19818609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First-line antiretroviral therapy in resource-limited settings: time to reconsider?
    Adlington R; Richens J; Shahmanesh M
    J Infect Dis; 2009 May; 199(9):1407; author reply 1407-8. PubMed ID: 19358673
    [No Abstract]   [Full Text] [Related]  

  • 16. A survey of the syntheses of active pharmaceutical ingredients for antiretroviral drug combinations critical to access in emerging nations.
    Pinheiro Edos S; Antunes OA; Fortunak JM
    Antiviral Res; 2008 Sep; 79(3):143-65. PubMed ID: 18571246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4 cell count-guided treatment interruption: be smart and wait for more evidence.
    Arduino R
    Clin Infect Dis; 2005 Mar; 40(5):735-7. PubMed ID: 15714421
    [No Abstract]   [Full Text] [Related]  

  • 18. [HIV-HBV-coinfection--diagnosis and therapy].
    Koch S; Göbels K; Oette M; Heintges T; Erhardt A; Häussinger D
    Dtsch Med Wochenschr; 2006 Aug; 131(34-35):1873-7. PubMed ID: 16915550
    [No Abstract]   [Full Text] [Related]  

  • 19. Recent advances in antiretroviral therapy of HIV infection.
    Vella S; Fragola V; Palmisano L
    J Biol Regul Homeost Agents; 1997; 11(1-2):60-3. PubMed ID: 9418165
    [No Abstract]   [Full Text] [Related]  

  • 20. Status of anti-HIV-1 chemotherapy in Japan.
    Oishi T; Sugiura W; Matsuda M; Abumi H; Okano A; Yamada K; Koike M; Taki M; Ishikawa M; Miura T; Fukutake K; Gouchi K; Ajisawa A; Iwamoto A; Hanabusa H; Mimaya J; Takamatsu J; Takata N; Kakishita E; Higasa S; Yoshioka A; Kashiwagi S; Shirahata A; Nagai Y
    Jpn J Infect Dis; 1999 Apr; 52(2):51-2. PubMed ID: 10817968
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.